| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Research Communications |
1 From the Department of Human Biology and Nutritional Sciences, University of Guelph, Canada.
Background: n-3 Fatty acid supplementation lowered serum triacylglycerol concentrations in studies in which most of the subjects were male. The effects of n-3 fatty acid supplementation in postmenopausal women receiving and not receiving hormone replacement therapy (HRT) have received little attention.
Objective: We sought to determine the effects of a fish-oil-derived n-3 fatty acid concentrate on serum lipid and lipoprotein risk factors for cardiovascular disease in postmenopausal women receiving and not receiving HRT, with an emphasis on serum triacylglycerol concentrations and the ratio of triacylglycerol to HDL cholesterol.
Design: Postmenopausal women (n = 36) were grouped according to exogenous hormone use and were randomly allocated to receive 8 capsules/d of either placebo oil (control) or n-3 fatty acid–enriched oil (supplement). The supplement provided 2.4 g eicosapentaenoic acid (EPA) plus 1.6 g docosahexaenoic acid (DHA) daily. Serum lipids and the fatty acid composition of serum phospholipids were determined on days 0 and 28.
Results: Supplementation with n-3 fatty acids was associated with 26% lower serum triacylglycerol concentrations (P < 0.0001), a 28% lower overall ratio of serum triacylglycerol to HDL cholesterol (P < 0.01), and markedly greater EPA and DHA concentrations in serum phospholipids (P < 0.05).
Conclusions: These results show that supplementation with a fish-oil–derived concentrate can favorably influence selected cardiovascular disease risk factors, particularly by achieving marked reductions in serum triacylglycerol concentrations and triacylglycerol:HDL cholesterol in postmenopausal women receiving and not receiving HRT. This approach could potentially reduce the risk of coronary heart disease by 27% in postmenopausal women.
Key Words: Fish oil • n-3 fatty acids • omega-3 fatty acids • total cholesterol • LDL cholesterol • HDL cholesterol • triacylglycerol • postmenopausal women • hormone replacement therapy • cardiovascular disease
This article has been cited by other articles:
|
|
 |
|
  K. Fekete, T. Marosvolgyi, V. Jakobik, and T. Decsi Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: a systematic review Am. J. Clinical Nutrition, June 1, 2009; 89(6): 2070S - 2084S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Daniel, M. L. McCullough, R. C. Patel, E. J. Jacobs, W. D. Flanders, M. J. Thun, and E. E. Calle Dietary Intake of {omega}-6 and {omega}-3 Fatty Acids and Risk of Colorectal Cancer in a Prospective Cohort of U.S. Men and Women Cancer Epidemiol. Biomarkers Prev., February 1, 2009; 18(2): 516 - 525. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Patterson and K. D. Stark Direct Determinations of the Fatty Acid Composition of Daily Dietary Intakes Incorporating Nutraceuticals and Functional Food Strategies to Increase n-3 Highly Unsaturated Fatty Acids J. Am. Coll. Nutr., October 1, 2008; 27(5): 538 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Rudkowska Functional foods for cardiovascular disease in women Menopause Int, June 1, 2008; 14(2): 63 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Lok, M. Allon, S. Donnelly, M. Dorval, B. Hemmelgarn, L. Moist, M. J. Oliver, M. Tonelli, and K. Stanley Design of the fish oil inhibition of stenosis in hemodialysis grafts (FISH) study Clinical Trials, August 1, 2007; 4(4): 357 - 367. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Faeh, K. Minehira, J.-M. Schwarz, R. Periasamy, S. Park, and L. Tappy Effect of Fructose Overfeeding and Fish Oil Administration on Hepatic De Novo Lipogenesis and Insulin Sensitivity in Healthy Men Diabetes, July 1, 2005; 54(7): 1907 - 1913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D Stark and B. J Holub Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy Am. J. Clinical Nutrition, May 1, 2004; 79(5): 765 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Laidlaw and B. J Holub Effects of supplementation with fish oil-derived n-3 fatty acids and {gamma}-linolenic acid on circulating plasma lipids and fatty acid profiles in women Am. J. Clinical Nutrition, January 1, 2003; 77(1): 37 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Holub Clinical nutrition: 4. Omega-3 fatty acids in cardiovascular care Can. Med. Assoc. J., March 1, 2002; 166(5): 608 - 615. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Crone, G. Gabriel, and T. N. Wise Non-Herbal Nutritional Supplements--The Next Wave: A Comprehensive Review of Risks and Benefits for the C-L Psychiatrist Psychosomatics, August 1, 2001; 42(4): 285 - 299. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
